Aduro Biotech Announces Upcoming Presentations on Oncology Programs at American Association for Cancer Research Meeting

Aduro BioTech, Inc. announces one oral and two poster presentations at the upcoming American Association of Cancer Research (AACR) Annual Meeting April 6th-10th in Washington, D.C. that highlight the breadth and progress of Aduro’s Listeria monocytogenes-based and cyclic dinucleotide (CDN)-based immunotherapy programs. The company also announces an oral presentation at the upcoming Cambridge Healthtech Institute Conference on Molecular Pattern Recognition Receptors April 11th-12th in Boston that highlights the use of CDN adjuvants for cancer and infectious disease vaccines.

Back to news